AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30419096 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (individualized moderate-intensity resistance, balance, and walking exercises, 2 daily sessions)
Number of subjects: 370
Study 30419096 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 370
Study 30419096 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group (control)
Number of subjects: 370
Study 30012641 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma proenkephalin A 119‐159 (penKid)
Number of subjects: 956
Study 25919484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 100
Study 25919484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23117168 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult non-cultivated bone marrow stem cells (group A)
Number of subjects: 43
Study 23117168 — intervention group
Group type: COMPARATOR
Intervention: No intervention (group B)
Number of subjects: 43
Study 22233789 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry-land strength training program (S)
Number of subjects: 24
Study 22233789 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation training program (ES)
Number of subjects: 24
Study 22233789 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 24
Study 20012122 — intervention group
Group type: EXPERIMENTAL
Intervention: High quality RCTs classified using the original cut off of the PEDro scale (cut off of 6)
Number of subjects: 18
Study 20012122 — intervention group
Group type: EXPERIMENTAL
Intervention: High quality RCTs classified using the modified cut off of the PEDro scale (cut off of 5)
Number of subjects: 18
Study 20012122 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear regression analysis between year of publication and quality rate
Number of subjects: 18
Study 18576903 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicloxacillin 500 mg alone
Number of subjects: 22
Study 18576903 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicloxacillin 500 mg plus probenecid 1 g
Number of subjects: 22
Study 18576903 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicloxacillin 500 mg plus cyclosporine 5 mg/kg
Number of subjects: 22
Study 18576903 — intervention group
Group type: EXPERIMENTAL
Intervention: ABCB1 exon 26 TT polymorphism
Number of subjects: 22
Study 15765455 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg morphine
Number of subjects: 81
Study 15765455 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg morphine
Number of subjects: 81
Study 15765455 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 81
Study 12455724 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant treatment with glutathione (1200 mg i.v. at the end of each dialysis session) and a vitamin E-bonded HD membrane (CL-E)
Number of subjects: 38
Study 12455724 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant treatment
Number of subjects: 38
Study 20670489 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous automated lumbar nucleotomy
Number of subjects: 158
Study 20670489 — intervention group
Group type: COMPARATOR
Intervention: Traditional macro-procedure discectomy
Number of subjects: 158
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency contraception knowledge among rural GPs
Number of subjects: 160
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency contraception knowledge among urban GPs
Number of subjects: 160
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of prescribing emergency contraception by urban GPs
Number of subjects: 160
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of prescribing emergency contraception by rural GPs
Number of subjects: 160
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: Female GPs prescribing emergency contraception
Number of subjects: 160
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: Male GPs prescribing emergency contraception
Number of subjects: 160
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of information about emergency contraception by urban GPs
Number of subjects: 160
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of information about emergency contraception by rural GPs
Number of subjects: 160
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of emergency contraception information in contraceptive discussions
Number of subjects: 160
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of information only if requested by women
Number of subjects: 160
Study 7854225 — intervention group
Group type: EXPERIMENTAL
Intervention: GPs providing information as a back-up to barrier methods
Number of subjects: 160
Study 1936472 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (metformin + glibenclamide), n = 60
Number of subjects: 116
Study 1936472 — intervention group
Group type: COMPARATOR
Intervention: Metformin monotherapy, n = 28
Number of subjects: 116
Study 1936472 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide monotherapy, n = 28
Number of subjects: 116
Study 1936472 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients, n = 69
Number of subjects: 116
Study 1936472 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-obese patients, n = 47
Number of subjects: 116
Study 1936472 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides
Number of subjects: 116
Study 1936472 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL-cholesterol
Number of subjects: 116
Study 7252648 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy intake (lipid) at 50 to 80 nonprotein kcal/kg/day
Number of subjects: 22
Study 7252648 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogen intake at 494 to 655 mg/kg/day with constant low energy intake (mean = 53 kcal/kg/day)
Number of subjects: 22
Study 7252648 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogen intake at higher energy intakes (mean = 81 kcal/kg/day)
Number of subjects: 22
Study 7252648 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy intake greater than 70 kcal/kg/day with nitrogen infusion of 430 to 560 mg/kg/day (2.7 to 3.5 gm protein/kg/day)
Number of subjects: 22
Study 31532136 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongyuan acupuncture
Number of subjects: 74
Study 31532136 — intervention group
Group type: COMPARATOR
Intervention: Scalp acupuncture
Number of subjects: 74
Study 28755104 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal esketamine (84 mg)
Number of subjects: 26
Study 28755104 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mirtazapine (30 mg)
Number of subjects: 26
Study 28755104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 24404992 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural anger management intervention
Number of subjects: 129
Study 24404992 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 129
Study 24089418 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferritin in postmenopausal women
Number of subjects: 3932
Study 24089418 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferritin in premenopausal women aged ≥ 46 y
Number of subjects: 3932
Study 24089418 — intervention group
Group type: COMPARATOR
Intervention: Hemoglobin
Number of subjects: 3932
Study 21298294 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 5 mg combined with fentanyl 25 μg
Number of subjects: 120
Study 21298294 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 7.5 mg combined with fentanyl 15 μg
Number of subjects: 120
Study 21298294 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 10 mg combined with fentanyl 10 μg
Number of subjects: 120
Study 19704396 — intervention group
Group type: EXPERIMENTAL
Intervention: Encouragement from at least 1 network member to use male condom
Number of subjects: 157
Study 19704396 — intervention group
Group type: EXPERIMENTAL
Intervention: Encouragement from at least 1 network member to use female condom
Number of subjects: 157
Study 19704396 — intervention group
Group type: EXPERIMENTAL
Intervention: Dense female condom conversation networks (at least 2 network members know one another)
Number of subjects: 157
Study 17235610 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg/day
Number of subjects: 15
Study 17235610 — intervention group
Group type: COMPARATOR
Intervention: Citalopram 20 mg/day
Number of subjects: 15
Study 16137055 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day rabeprazole-based triple therapy (rabeprazole 10 mg twice daily, clarithromycin 500 mg twice daily, furazolidone 100 mg twice daily)
Number of subjects: 95
Study 16137055 — intervention group
Group type: COMPARATOR
Intervention: 7-day triple standard therapy (rabeprazole 10 mg twice daily, clarithromycin 500 mg twice daily, furazolidone 100 mg twice daily)
Number of subjects: 95
Study 16137055 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day rabeprazole-based triple therapy
Number of subjects: 95
Study 16137055 — intervention group
Group type: COMPARATOR
Intervention: 7-day triple standard therapy
Number of subjects: 95
Study 10899240 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 24, 48, 96 microg
Number of subjects: 16
Study 10899240 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 100, 200, 400 microg
Number of subjects: 16
Study 10899240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9401929 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen (Froben) 50 mg, 3 times per day for 30 days
Number of subjects: 19
Study 9401929 — intervention group
Group type: COMPARATOR
Intervention: Placebo drug
Number of subjects: 19
Study 9401929 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgically treated sites (both Flurbiprofen and placebo)
Number of subjects: 19
Study 8419023 — intervention group
Group type: EXPERIMENTAL
Intervention: t-PA (0.8 mg/kg i.v.; maximum, 80 mg) plus conventional antianginal therapy
Number of subjects: 306
Study 8419023 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus conventional antianginal therapy
Number of subjects: 306
Study 3530602 — intervention group
Group type: EXPERIMENTAL
Intervention: iopamidol
Number of subjects: 58
Study 3530602 — intervention group
Group type: COMPARATOR
Intervention: iohexol
Number of subjects: 58
Study 31820599 — intervention group
Group type: EXPERIMENTAL
Intervention: Jingu three-needle therapy combined with Xingnao Kaiqiao acupuncture
Number of subjects: 96
Study 31820599 — intervention group
Group type: COMPARATOR
Intervention: Xingnao Kaiqiao acupuncture (control group)
Number of subjects: 96
Study 29505863 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical fluorouracil (5‐FU) 5%
Number of subjects: 0
Study 29505863 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control cream
Number of subjects: 0
Study 27553623 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser treatment (PBMT with 904-nm GaAs diode laser, 30 mW average power, 25 Hz pulse frequency, 3.6 J/cm2)
Number of subjects: 30
Study 27553623 — intervention group
Group type: COMPARATOR
Intervention: Sham (placebo) treatment
Number of subjects: 30
Study 27553623 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser treatment (PBMT)
Number of subjects: 30
Study 24920270 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorella (5 g/day)
Number of subjects: 63
Study 24920270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 22579072 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (24 forms simplified Tai Chi)
Number of subjects: 389
Study 22579072 — intervention group
Group type: COMPARATOR
Intervention: Stretching and toning exercise
Number of subjects: 389
Study 20455694 — intervention group
Group type: EXPERIMENTAL
Intervention: L. fermentum CECT5716 (Group A)
Number of subjects: 352
Study 20455694 — intervention group
Group type: EXPERIMENTAL
Intervention: L. salivarius CECT5713 (Group B)
Number of subjects: 352
Study 20455694 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic therapy (Group C)
Number of subjects: 352
Study 20455694 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic groups (A and B)
Number of subjects: 352
Study 19017589 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy plus cognitive behavior therapy
Number of subjects: 344
Study 19017589 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy
Number of subjects: 344
Study 19017589 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study 16097043 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (Met)
Number of subjects: 32
Study 16097043 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Met)
Number of subjects: 32
Study 15458100 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) technology used in developed virtual environments (VE) for the treatment of eating disorders.
Number of subjects: 0
Study 12135314 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (ACE inhibitor)
Number of subjects: 18
Study 12135314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (calcium antagonist)
Number of subjects: 18
Study 12135314 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C infusion
Number of subjects: 18
Study 12135314 — intervention group
Group type: COMPARATOR
Intervention: L-NMMA (nitric oxide synthase inhibitor)
Number of subjects: 18
Study 9649005 — intervention group
Group type: EXPERIMENTAL
Intervention: Background music and conversation related to the patient's complaints (n=50)
Number of subjects: 221
Study 9649005 — intervention group
Group type: EXPERIMENTAL
Intervention: Background music and conversation unrelated to the patient (n=53)
Number of subjects: 221
Study 9649005 — intervention group
Group type: EXPERIMENTAL
Intervention: Background music only, with staff maintaining silence (n=49)
Number of subjects: 221
Study 9649005 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete silence (n=47)
Number of subjects: 221
Study 7517409 — intervention group
Group type: EXPERIMENTAL
Intervention: Zatosetron (100 micrograms/kg) in dogs
Number of subjects: 28
Study 7517409 — intervention group
Group type: EXPERIMENTAL
Intervention: Zatosetron (50 mg) in men
Number of subjects: 28
Study 7517409 — intervention group
Group type: COMPARATOR
Intervention: Placebo in men
Number of subjects: 28
Study 2638185 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer dentifrice (0.3% triclosan and 2% copolymer)
Number of subjects: 118
Study 2638185 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 118
Study 4947492 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard daily continuation chemotherapy with isoniazid plus PAS
Number of subjects: 0
Study 4947492 — intervention group
Group type: COMPARATOR
Intervention: Fully supervised treatment with streptomycin and high dosage isoniazid, given twice weekly
Number of subjects: 0
Study 4947492 — intervention group
Group type: COMPARATOR
Intervention: 3 months sanatorium treatment
Number of subjects: 0
Study 31648149 — intervention group
Group type: EXPERIMENTAL
Intervention: GPiam‐DBS ON
Number of subjects: 11
Study 31648149 — intervention group
Group type: COMPARATOR
Intervention: GPiam‐DBS OFF
Number of subjects: 11
Study 31648149 — intervention group
Group type: EXPERIMENTAL
Intervention: GPiam‐DBS
Number of subjects: 11
Study 25969966 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week balance training program
Number of subjects: 70
Study 25969966 — intervention group
Group type: COMPARATOR
Intervention: Usual training
Number of subjects: 70
Study 23077972 — intervention group
Group type: EXPERIMENTAL
Intervention: 48-hour ABPM with BP measured at 20-min intervals during the day and 30-min intervals at night.
Number of subjects: 3344
Study 23077972 — intervention group
Group type: COMPARATOR
Intervention: 24-hour ABPM with BP measured at the same intervals as above.
Number of subjects: 3344
Study 23077972 — intervention group
Group type: EXPERIMENTAL
Intervention: ABPM profiles modified to simulate a sampling rate of one BP measurement every 1 or 2 hours for 48 hours.
Number of subjects: 3344
Study 23077972 — intervention group
Group type: COMPARATOR
Intervention: ABPM for only 24 hours.
Number of subjects: 3344
Study 22145912 — intervention group
Group type: EXPERIMENTAL
Intervention: ProMo intervention (includes Standard Care and a year-long program with evaluation/modification of environmental hazards, guidance for safe walking, pain management, progressive home exercise program, and physical activity counseling)
Number of subjects: 81
Study 22145912 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (written home exercise program with 5-7 exercises for lower limbs)
Number of subjects: 81
Study 19891770 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose adenosine infusion
Number of subjects: 9
Study 19891770 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 9
Study 17257450 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) with therapeutic drug monitoring (TDM) of mycophenolic acid (MPA) trough levels
Number of subjects: 0
Study 17257450 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF) without therapeutic drug monitoring (TDM)
Number of subjects: 0
Study 12771969 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g spread enriched with 1.6 g plant sterols as fatty acid esters
Number of subjects: 185
Study 12771969 — intervention group
Group type: COMPARATOR
Intervention: Control spread
Number of subjects: 185
Study 11025373 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical prostatectomy only
Number of subjects: 158
Study 11025373 — intervention group
Group type: COMPARATOR
Intervention: Postoperative hormonal treatment
Number of subjects: 158
Study 11025373 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiotherapy
Number of subjects: 158
Study 9334909 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 50
Study 9334909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 7943921 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous induction with sodium thiopental and muscle relaxants (succinylcholine chloride or alcuronium chloride)
Number of subjects: 20
Study 7943921 — intervention group
Group type: COMPARATOR
Intervention: Awake intubation under intravenous sedation with diazepam and topical anesthesia with 4% lidocaine
Number of subjects: 20
Study 31994366 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasopressin
Number of subjects: 0
Study 31994366 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 0
Study 31994366 — intervention group
Group type: EXPERIMENTAL
Intervention: Selepressin
Number of subjects: 0
Study 31994366 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II
Number of subjects: 0
Study 31994366 — intervention group
Group type: COMPARATOR
Intervention: Nitric oxide synthase inhibitors
Number of subjects: 0
Study 31994366 — intervention group
Group type: COMPARATOR
Intervention: Methylene blue
Number of subjects: 0
Study 31994366 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 0
Study 30706575 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS-guided fluid management
Number of subjects: 201
Study 30706575 — intervention group
Group type: COMPARATOR
Intervention: Clinical method-guided management (Control)
Number of subjects: 201
Study 30688281 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed primary closure (DPC)
Number of subjects: 34
Study 30688281 — intervention group
Group type: COMPARATOR
Intervention: Primary closure (PC)
Number of subjects: 34
Study 26137575 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose R-bambuterol (2.5 mg, 5 mg, or 10 mg)
Number of subjects: 48
Study 26137575 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose R-bambuterol (5 mg)
Number of subjects: 48
Study 26137575 — intervention group
Group type: COMPARATOR
Intervention: Single-dose rac-bambuterol (10 mg)
Number of subjects: 48
Study 24277856 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal OXT treatment (24 IU)
Number of subjects: 20
Study 24277856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 22019033 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated biofeedback along with pelvic floor muscle exercises and behavioral modification
Number of subjects: 80
Study 22019033 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy (behavioral modification only)
Number of subjects: 80
Study 19475640 — intervention group
Group type: EXPERIMENTAL
Intervention: High adiponectin concentrations
Number of subjects: 1407
Study 19475640 — intervention group
Group type: EXPERIMENTAL
Intervention: High adiponectin concentrations among moderately/very active men
Number of subjects: 1407
Study 19475640 — intervention group
Group type: EXPERIMENTAL
Intervention: High adiponectin concentrations among sedentary/minimally active men
Number of subjects: 1407
Study 19475640 — intervention group
Group type: EXPERIMENTAL
Intervention: C-peptide and leptin
Number of subjects: 1407
Study 19475640 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin concentrations
Number of subjects: 1407
Study 16767844 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg/day) and E (100 mg/day) supplementation
Number of subjects: 14
Study 16767844 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 14
Study 14709123 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone infusion (1000 mg in 300 mL normal saline)
Number of subjects: 52
Study 14709123 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone infusion (1000 mg in 300 mL normal saline) + Chlorpheniramine bolus (10 mg IV)
Number of subjects: 52
Study 14709123 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 11504985 — intervention group
Group type: EXPERIMENTAL
Intervention: Perinatally HIV‐1‐infected children
Number of subjects: 212
Study 9597289 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation under local anaesthetic
Number of subjects: 33
Study 9597289 — intervention group
Group type: EXPERIMENTAL
Intervention: External splintage with Plaster of Paris (POP)
Number of subjects: 33
Study 9597289 — intervention group
Group type: COMPARATOR
Intervention: No external splintage (none-POP)
Number of subjects: 33